a public good project by the
Synthesis
Company
of California

© 2026

Hugo F. Fernández | doi.page

0 works0 citations0 h-index

Hugo F. Fernández

Memorial Healthcare System(US)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Multiple Myeloma Research and Treatments

Most-Cited Works

→ Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation(2010)2,713 cited
→ Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia(2012)1,935 cited
→ Anthracycline Dose Intensification in Acute Myeloid Leukemia(2009)902 cited
→ Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes(2017)652 cited
→ Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease(2019)435 cited
→ MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation(2009)329 cited

→ Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia(2012)

301 cited

→ Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality(2002)225 cited

→ Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS(2012)201 cited

→ Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia(2013)200 cited